Scleroderma renal crisis or thrombotic thrombocytopenic purpura: Seeing through the masquerade

Laboratory Medicine

Volumn 46, Issue 2, 2015, Pages e39-e44

  Keeler, Emily ^a   Fioravanti, Gloria ^a   Samuel, Bensson ^a   Longo, Santo ^a  

^a Health Network   (United States)

Author keywords

ACE inhibitor; Anemia; Renal failure; Scleroderma; Thrombolysis; Thrombotic thrombocytopenic purpura

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA DIRECTED RNA POLYMERASE III ANTIBODY; ENZYME ANTIBODY; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE KIDNEY FAILURE; ADULT; ANEMIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; LABORATORY TEST; LUNG EDEMA; MALIGNANT HYPERTENSION; MIDDLE AGED; PLASMAPHERESIS; POSITIVE END EXPIRATORY PRESSURE; SCLERODERMA; SCLERODERMA RENAL CRISIS; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; DIFFERENTIAL DIAGNOSIS; HYPERTENSION, RENAL; PATHOPHYSIOLOGY; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTENSION, RENAL; MIDDLE AGED; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 84949814558     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LM72AM5XFHZYOQCB     Document Type: Article

References (8)

1. Longo DL, Fauci A, Kasper D, et al. Harrison's Prinicples of Internal Medicine. 18th edn. New York: McGraw-Hill Companies Inc. 2012:2766-2768, 2757-2759.
2. Denton CP, Lapadula G, Mouthon L, Müller-Ladner U. Renal complications and scleroderma renal crisis. Rheumatology (Oxford). 2009;48(suppl 3):iii32-iii35.
3. Okano Y, Steen VD, Medsger TA Jr. Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med. 1993;119(10):1005-1013.
4. Penn H, Howie AJ, Kingdon EJ, et al. Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM. 2007;100(8):485-494.
5. Kumar V, Abbas AK, Fausto N.. Robbins and Cotran Pathologic Basis of Disease. Philadelphia: Elsevier Saunders; 2005.
6. Papadakis MA, McPhee SJ. Current Medical Diagnosis and Treatment. New York: McGraw-Hill Companies Inc; 2013:543.
7. Shanmugam VK, Steen VD. Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management. Curr Opin Rheumatol. 2012;24(6):669-676.
8. Abudiab M, Krause ML, Fidler ME, Nath KA, Norby SM. Differentiating scleroderma renal crisis from other causes of thrombotic microangiopathy in a postpartum patient. Clin Nephrol. 2013;80(4):293-297.